DEVELOPMENT AND VALIDATION OF HIGH-PERFORMANCE THIN LAYERCHROMATOGRAPHIC METHOD FOR CIPROFLOXACIN BY QUALITY BY DESIGN APPROACH
DOI:
https://doi.org/10.22159/ajpcr.2021.v14i12.42627Keywords:
Ciprofloxacin, High-performance thin-layer chromatography, Quality by design, Box-Behnken DesignAbstract
Objective: The aim of this paper is to create a new, systematic high-performance thin-layer chromatography (HPTLC) method for ciprofloxacin that is based on quality by design (QbD).
Methods: The mobile phase was chloroform: IPA: H2O: Formic Acid (2:7:0.5:0.5V/V), and the chromatographic separation was performed on aluminum-backed silica gel 60 F254 plates. Ciprofloxacin was detected using UV light at 278nm. In factor screening studies, a 3-factor 17-run standard 3-level factorial design was used, and a Box-Behnken design was used to optimize HPTLC experimental parameters for obtaining anticipated chromatographic conditions. The basic method parameters were tested to understand risk assessment. Three independent parameters, such as saturation time, band duration, and migration distance, were chosen and analyzed based on the risk assessment to see if these three parameters influenced the responses. For ciprofloxacin, the method produces a compact and well-resolved band at Rf = 0.40 0.02. In the linear regression analysis performed on ciprofloxacin, the regression coefficient was found to be r2 = 0.996.
Results: According to the International Council on Harmonization (ICH) guidelines, it was validated for validation parameters such as accuracy, precision, robustness, the limit of detection, and the limit of quantification. The proposed method for ciprofloxacin determination was found to be straightforward, precise, reliable, stable, and sensitive.
Conclusion: The QbD method produced a more robust method that can generate accurate, high-quality, and reliable data during the process, and it can be effectively used in the routine inspection of Ciprofloxacin in the tablets dosage form.
Downloads
References
Bera AK, De Amit K. RP-HPLC method development and validation for the determination of ciprofloxacin from marketed tablet dosage forms. J Chem Pharm Res 2014;6:1214-8.
Krishna JR, Naga B, Sandhya SH. Development and validation of RP-HPLC method for the simultaneous estimation of ciprofloxacin hydrochloride and ornidazole in combined pharmaceutical dosage form. J Adv Pharm Educ Res 2014;4:440-3.
Ali SA, Mmuo CC, Abdulraheem RO and Abdulkareem SS. High performance liquid chromatography (HPLC) Method development and validation indicating assay for ciprofloxacin hydrochloride. J Appl Pharm Sci 2011;1:239.
Wu SS, Chein CY, Wen YH. Analysis of ciprofloxacin by a simple high-performance liquid chromatography method. J Chrom Sci 2008;46:490-5.
Vishnuraj AR, Gurupadayya BM, Kathirvel S. Stability indicating analytical method development and validation of ciprofloxacin by RP-HPLC with fluorescence detector. Int J Pharm Qual Ass 2021;12:51-6.
Karunasree A, Thejomoorthy K, Jaffer M, Padmanabha RY, Ramalingam P. In vitro protein binding study of ciprofloxacin by new UV-spectrophotometric method. Int J Pharm Technol Res 2010;2:1150-4.
Nijhu RS, Jhanker YM, Sutradhar KB. Development of an assay method for simultaneous determination of ciprofloxacin and naproxen by UV spectrophotometric method. Stam J Pharma Sci 1970;4:84-90.
Novakovic J, Nesmerak K, Nova H, Filka K. An HPTLC method for the determination and the purity control of ciprofloxacin HCL in coated tablets. J Pharm Biomed Anal 2001;25:957-64.
Maya MT, Gonçalves NJ, Silva NB, Morais JA. Simple high-performance liquid chromatographic assay for the determination of ciprofloxacin in human plasma with ultraviolet detection. J Chromatogr B Biomed Sci Appl 2001;755:305-9.
Ali J, Pramod K, Tahir M, Charoo N, Ansari S. Pharmaceutical product development: A quality by design approach. Int J Pharm Investig 2016;6:129.
Bezerra MA, Santelli RE, Oliveira EP, Villar LS, Escaleira LA. Response surface methodology (RSM) as a tool for optimization in analytical chemistry. Talanta 2008;76:965-77.
Ferreira SL. Box-Behnken design: An alternative for the optimization of analytical methods. Anal Chim Acta 2007;597:179-86.
Fukuda IM, Pinto CF, Moreira CS, Saviano AM, Lourenço FR. Design of experiments (DoE) applied to pharmaceutical and analytical quality by design (QbD). Braz J Pharm Sci 2018;54:e01006.
Vogt FG, Kord AS. Development of quality-by-design analytical methods. J Pharm Sci 2011;100:797-812.
Published
How to Cite
Issue
Section
Copyright (c) 2021 Shraddha Tathe
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.